Research Operations
A Guide to System Integrations and Single Sign-On for Clinical Operations Teams
The growing complexity of clinical trials is being met with a new generation of eClinical tools – electronic data capture, centralized trial platforms, and risk-based management tools.
Inova Health System Uses Advarra eReg Workflows and Integrations to Improve Regulatory Efficiency
Expanding Our Global Consulting Expertise to Solve Mission-Critical Issues
Elevating our consulting capabilities to accelerate clinical research and bring therapies to market sooner.
Top 10 Educational Resources of 2020
We strive to create meaningful and relevant content for the clinical research community. Check out our top resources of 2020.
What is the ROI of eLearning?
Learn how to launch an eLearning program for Clinical Research. eLearning is a tool for software implementations, staff development, and procedure training.
Community-Based Participatory Research (CBPR): A Framework for Community Engagement
Community-based participatory research (CBPR) is utilized to reduce racial and ethnic health disparities in under-represented populations.
Demonstrating the Impact of the Longboat Portal on Recruitment Success
Standardization and the Importance of Medical Coding Dictionaries in Clinical Trials
Learn more about the importance of medical coding dictionaries, their common uses, and best practices.
Q&A – Racial Diversity in Clinical Trials: Building Trust in Participant Engagement
Our experts answered some of the most popular questions from "Racial Diversity in Clinical Trials: Building Trust in Participant Engagement."
UC Denver, Anschutz Medical Campus and Novant Health Leverage Advarra Technology to Keep Research Moving During COVID-19
The COVID-19 pandemic created unique challenges for research professionals, forcing clinical and operational staff to navigate an increasingly remote research environment with reduced resources. University of Colorado Anschutz and Novant Health maintained compliance and efficiency remotely while maintaining full visibility into their studies.
Takeaways From the FDA’s VRBPAC Meeting – October 22, 2020
On October 22, 2020, the FDA's VRBPAC met to discuss the development, authorization, and licensure of vaccines to prevent COVID-19.